Clinical Trial Update: Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating antenatal azithromycin to prevent preterm birth in pregnant women with vaginal cerclage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Preterm Birth | Phase 4 | Status: COMPLETED